Skip to main content

Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

Association between cannabis use and symptom dimensions in schizophrenia spectrum disorders: an individual participant data meta-analysis on 3053 individuals.

PMID: 37731936
Journal: EClinicalMedicine
Year: 2023
Reference: EClinicalMedicine. 2023 Sep 8;64:102199. doi: 10.1016/j.eclinm.2023.102199. eCollection 2023 Oct.
Impact factor:
Publication type: Paper in international publication
Authors: Addington, Jean Margaret; Amoretti, Silvia; Andreassen, Ole Andreas; Argote, Mathilde; Asmal, Laila; Baudin, Gregoire; Bechdolf, Andreas; Brambilla, Paolo; Brunelin, Jerome; Cookey, Jacob et al.
DOI: 10.1016/j.eclinm.2023.102199

Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort.

PMID: 36675312
Journal: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Year: 2023
Reference: Int J Mol Sci. 2023 Jan 16;24(2):1797. doi: 10.3390/ijms24021797.
Impact factor:
Publication type: Paper in international publication
Authors: Clemente, Susana; Fernandez-Lorenzo, Ana; Garcia-Romero, Ruth; Laserna-Mendieta, Emilio; Lopez-Cauce, Beatriz; Lopez-Fernandez, Luis A; Loverdos, Ines; Lucendo, Alfredo J; Magallares, Lorena; Marin-Jimenez, Ignacio et al.
DOI: 10.3390/ijms24021797

Association between sagittal alignment and loads at the adjacent segment in the fused spine: a combined clinical and musculoskeletal modeling study of 205 patients with adult spinal deformity.

PMID: 36526952
Journal: EUROPEAN SPINE JOURNAL
Year: 2023
Reference: Eur Spine J. 2023 Feb;32(2):571-583. doi: 10.1007/s00586-022-07477-4. Epub 2022 Dec 17.
Impact factor:
Publication type: Paper in international publication
Authors: Alanay, Ahmet; Behm, Pascal; Fekete, Tamas F; Ferguson, Stephen J; Galbusera, Fabio; Haschtmann, Daniel; Ignasiak, Dominika; Jeszenszky, Dezso; Karaman, Muhammed Ilkay; Kleinstuck, Frank et al.
DOI: 10.1007/s00586-022-07477-4

Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis.

PMID: 36779595
Journal: HAEMATOLOGICA
Year: 2023
Reference: Haematologica. 2023 Jul 1;108(7):1900-1908. doi: 10.3324/haematol.2022.281958.
Impact factor:
Publication type: Paper in international publication
Authors: Abid, Muhammad Bilal; Aljurf, Mahmoud; Assal, Amer; Badar, Talha; Badawy, Sherif M; Ballen, Karen; Beitinjaneh, Amer; Cerny, Jan; Chhabra, Saurabh; DeFilipp, Zachariah et al.
DOI: 10.3324/haematol.2022.281958

Association of class II HLA alleles with susceptibility to develop immune-mediated diseases in Paraguayan patients.

PMID: 36543746
Journal: International Journal of Immunogenetics
Year: 2023
Reference: Int J Immunogenet. 2023 Feb;50(1):12-18. doi: 10.1111/iji.12609. Epub 2022 Dec 21.
Impact factor:
Publication type: Paper in international publication
Authors: Acosta, Maria Eugenia; Acosta-Colman, Isabel; Avila-Pedretti, Gabriela; Ayala-Lugo, Ana; Cabrera-Villalba, Sonia; Duarte, Margarita; Jolly, Valerie; Julia, Antonio; Langjahr, Patricia; Marsal, Sara et al.
DOI: 10.1111/iji.12609

Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple Sclerosis.

PMID: 36534392
Journal: JAMA Neurology
Year: 2023
Reference: JAMA Neurol. 2023 Feb 1;80(2):151-160. doi: 10.1001/jamaneurol.2022.4655.
Impact factor:
Publication type: Paper in international publication
Authors: Arrambide, Georgina; Auger, Cristina; Carbonell-Mirabent, Pere; Castillo, Joaquin; Cobo-Calvo, Alvaro; Comabella, Manuel; Galan, Ingrid; Midaglia, Luciana; Montalban, Xavier; Nos, Carlos et al.
DOI: 10.1001/jamaneurol.2022.4655

Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer.

PMID: 36593068
Journal: Journal for ImmunoTherapy of Cancer
Year: 2023
Reference: J Immunother Cancer. 2023 Jan;11(1):e005493. doi: 10.1136/jitc-2022-005493.
Impact factor:
Publication type: Paper in international publication
Authors: Ambrosini, Margherita; Barretta, Francesco; Corti, Francesca; Cremolini, Chiara; Elez, Maria Elena; Fakih, Marwan; Fenocchio, Elisabetta; Intini, Rossana; Jayachandran, Priya; Lonardi, Sara et al.
DOI: 10.1136/jitc-2022-005493

Association of intravenous thrombolysis and pre-interventional reperfusion: a post hoc analysis of the SWIFT DIRECT trial.

PMID: 36396433
Journal: Journal of NeuroInterventional Surgery
Year: 2023
Reference: J Neurointerv Surg. 2023 Nov;15(e2):e232-e239. doi: 10.1136/jnis-2022-019585. Epub 2022 Nov 17.
Impact factor:
Publication type: Paper in international publication
Authors: Abdala, Mariamo; Albucher, Jean Francois; Anton, Alfonso; Bassat, Quique; Beltran-Agullo, Laura; Bila, Rubao; Buetikofer, Lukas; Chiconela, Helio; Cuadrado, Daniel; Dacal, Elena et al.
DOI: 10.1136/jnis-2022-019585

Association of magnetic resonance imaging phenotypes and serum biomarker levels with treatment response and long-term disease outcomes in multiple sclerosis patients.

PMID: 37754568
Journal: EUROPEAN JOURNAL OF NEUROLOGY
Year: 2023
Reference: Eur J Neurol. 2023 Sep 27. doi: 10.1111/ene.16077.
Impact factor:
Publication type: Paper in international publication
Authors: Castillo, Joaquin; Comabella, Manuel; Comabella, Manuel; Fissolo, Nicolas; Midaglia, Luciana; Miro, Berta; Montalban, Xavier; Rio, Jordi; Rio, Jordi; Rovira, Alex et al.
DOI: 10.1111/ene.16077

Association of Mortality and Risk of Epilepsy With Type of Acute Symptomatic Seizure After Ischemic Stroke and an Updated Prognostic Model.

PMID: 37036702
Journal: JAMA Neurology
Year: 2023
Reference: JAMA Neurol. 2023 Apr 10. doi: 10.1001/jamaneurol.2023.0611.
Impact factor:
Publication type: Paper in international publication
Authors: Abraira, Laura; Alvarez-Sabin, Jose; Baumann, Christian R; Bayona-Ortiz, Hernan; Bentes, Carla; Bicciato, Giulio; Brigo, Francesco; Conrad, Julian; Dohler, Nico; Duncan, John S et al.
DOI: 10.1001/jamaneurol.2023.0611

Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy Drugs.

PMID: 36848127
Journal: JAMA Neurology
Year: 2023
Reference: JAMA Neurol. 2023 Apr 1;80(4):397-403. doi: 10.1001/jamaneurol.2023.0010.
Impact factor:
Publication type: Paper in international publication
Authors: Alvarez-Cermeno, Jose Carlos; Alvarez-Lafuente, Roberto; Brieva, Luis; Cabrera-Maqueda, Jose Maria; Casanova, Bonaventura; Chico-Garcia, Juan Luis; Comabella, Manuel; Costa-Frossard, Lucienne; Dominguez-Mozo, Maria Inmaculada; Eichau, Sara et al.
DOI: 10.1001/jamaneurol.2023.0010

Association of Time of Day With Outcomes Among Patients Triaged for a Suspected Severe Stroke in Nonurban Catalonia.

PMID: 36848432
Journal: STROKE
Year: 2023
Reference: Stroke. 2023 Mar;54(3):770-780. doi: 10.1161/STROKEAHA.122.041013. Epub 2023 Feb 27.
Impact factor:
Publication type: Paper in international publication
Authors: Abad, Fontcuberta; Abidi, El; Abilleira, Sonia; Adell, Vanessa; Agamez, Segovia; Agramunt, Nuria; Aguilo, Oriol; Ajenjo, Prieto; Alaez, San Juan; Alami, Khlifi et al.
DOI: 10.1161/STROKEAHA.122.041013

Association of Very Early Treatment Initiation With the Risk of Long-Term Disability in Patients With a First Demyelinating Event.

PMID: 37468284
Journal: NEUROLOGY
Year: 2023
Reference: Neurology. 2023 Jul 19:10.1212/WNL.0000000000207664. doi: 10.1212/WNL.0000000000207664.
Impact factor:
Publication type: Paper in international publication
Authors: Alvarez, Javier Villacieros; Alvarez, Javier Villacieros; Arrambide, Georgina; Auger, Cristina; Carbonell-Mirabent, Pere; Castillo, Joaquin; Cobo-Calvo, Alvaro; Comabella, Manuel; Galan, Ingrid; Midaglia, Luciana Soledad et al.
DOI: 10.1212/WNL.0000000000207664

Associations of sNfL with clinico-radiological measures in a large MS population.

PMID: 36427295
Journal: Annals of Clinical and Translational Neurology
Year: 2023
Reference: Ann Clin Transl Neurol. 2023 Jan;10(1):84-97. doi: 10.1002/acn3.51704. Epub 2022 Nov 25.
Impact factor:
Publication type: Paper in international publication
Authors: Akgun, Katja; Arrambide, Georgina; Bermel, Robert A; Calabresi, Peter A; Canissario, Ryan; Comabella, Manuel; Fisher, Elizabeth; Fitzgerald, Kathryn C; Hersh, Carrie M; Hyland, Megan H et al.
DOI: 10.1002/acn3.51704

Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC.

PMID: 36793385
Journal: JTO clinical and research reports
Year: 2023
Reference: JTO Clin Res Rep. 2022 Nov 8;4(1):100431. doi: 10.1016/j.jtocrr.2022.100431. eCollection 2023 Jan.
Impact factor:
Publication type: Paper in international publication
Authors: Aurora-Garg, Deepti; Ayers, Mark; Cristescu, Razvan; Felip, Enriqueta; Gadgeel, Shirish; Garassino, Marina C; Garon, Edward B; Halmos, Balazs; Horinouchi, Hidehito; Hui, Rina et al.
DOI: 10.1016/j.jtocrr.2022.100431

Asymmetrical Plasmon Distribution in Hybrid AuAg Hollow/Solid Coded Nanotubes.

PMID: 36985887
Journal: Nanomaterials
Year: 2023
Reference: Nanomaterials (Basel). 2023 Mar 9;13(6):992. doi: 10.3390/nano13060992.
Impact factor:
Publication type: Paper in international publication
Authors: Arbiol, Jordi; Arenal, Raul; Bastus, Neus G; Genc, Aziz; Patarroyo, Javier; Puntes, Victor; Sancho-Parramon, Jordi et al.
DOI: 10.3390/nano13060992

Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial.

PMID: 38048793
Journal: LANCET
Year: 2023
Reference: Lancet. 2023 Dec 1:S0140-6736(23)02405-4. doi: 10.1016/S0140-6736(23)02405-4.
Impact factor:
Publication type: Paper in international publication
Authors: Alarcon, Jesus; Amoretti, Silvia; Angelergues, Antoine; B Menezes, Ana Maria; Barros, Fernando C; Colombo, Nicoletta; D'Hondt, Veronique; Dahlstrand, Hanna; De Giorgi, Ugo; Duska, Linda et al.
DOI: 10.1016/S0140-6736(23)02405-4

Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial.

PMID: 37290461
Journal: LANCET
Year: 2023
Reference: Lancet. 2023 Jun 2:S0140-6736(23)00922-4. doi: 10.1016/S0140-6736(23)00922-4.
Impact factor:
Publication type: Paper in international publication
Authors: Albiges, Laurence; Angel, Martin; Bergthold, Guillaume; Chahoud, Jad; Choueiri, Toni K; de Velasco, Guillermo; Gupta, Suyasha; Huseni, Mahrukh; Kalaitzidou, Melania; Khan, Omara et al.
DOI: 10.1016/S0140-6736(23)00922-4

Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform.

PMID: 36940261
Journal: ONCOLOGIST
Year: 2023
Reference: Oncologist. 2023 Jun 2;28(6):553-e472. doi: 10.1093/oncolo/oyad022.
Impact factor:
Publication type: Paper in international publication
Authors: Ajani, Jaffer; Al-Sakaff, Nedal; Allen, Simon; Alsina Maqueda, Maria; Cha, Edward; Gan, Xinxin; Kim, Kyu-Pyo; Ko, Andrew H; Lacy, Jill; Lau, Janet et al.
DOI: 10.1093/oncolo/oyad022

Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial.

PMID: 37516125
Journal: LANCET
Year: 2023
Reference: Lancet. 2023 Jul 26:S0140-6736(23)01049-8. doi: 10.1016/S0140-6736(23)01049-8.
Impact factor:
Publication type: Paper in international publication
Authors: Ailani, Jessica; Ashina, Messoud; Boinpally, Ramesh; De Abreu Ferreira, Rosa; Finnegan, Michelle; Goadsby, Peter J; Guo, Hua; Lipton, Richard B; Lu, Kaifeng; McCusker, Emily et al.
DOI: 10.1016/S0140-6736(23)01049-8

Atraumatic Fracture of the Femoral Component of a Cemented Total Knee Arthroplasty: A Case Report.

PMID: 36812361
Journal: JBJS case connector
Year: 2023
Reference: JBJS Case Connect. 2023 Feb 22;13(1). doi: 10.2106/JBJS.CC.22.00641. eCollection 2023 Jan 1.
Impact factor:
Publication type: Letter or abstract
Authors: Castellet, Enric; Joshi-Jubert, Nayana; Minguell, Joan; Pijoan, Joan; Pujol, Oriol; Reverte, Merce; Reverte, Merce et al.
DOI: 10.2106/JBJS.CC.22.00641

Atrial myxoma.

PMID: 36890091
Journal: MEDICINA CLINICA
Year: 2023
Reference: Med Clin (Barc). 2023 Jun 23;160(12):e23. doi: 10.1016/j.medcli.2023.01.018. Epub 2023 Mar 6.
Impact factor:
Publication type: Paper in national publication
Authors: Barriuso Barrado, Ignacio; Bascompte Claret, Ramon; Ramirez Martinez, Tania; Vigil-Escalera Lopez, Carlota; Vigil-Escalera Lopez, Carlota; Viles Beltran, Maria Dolors et al.
DOI: 10.1016/j.medcli.2023.01.018

Attentional Bias Modification Training Based on Virtual Reality and Eye Tracking in Anorexia Nervosa Patients.

PMID: 37762873
Journal: Journal of Clinical Medicine
Year: 2023
Reference: J Clin Med. 2023 Sep 12;12(18):5932. doi: 10.3390/jcm12185932.
Impact factor:
Publication type: Paper in international publication
Authors: Ascione, Mariarca; Carulla-Roig, Marta; Ferrer-Garcia, Marta; Gutierrez-Maldonado, Jose; Gutierrez-Maldonado, Jose; Meschberger-Annweiler, Franck-Alexandre; Meschberger-Annweiler, Franck-Alexandre; Miquel-Nabau, Helena; Moreno-Sanchez, Manuel; Porras-Garcia, Bruno et al.
DOI: 10.3390/jcm12185932

Attention-deficit/hyperactivity disorder is associated with increased risk of cardiovascular diseases: A systematic review and meta-analysis.

PMID: 37720588
Journal: JCPP advances
Year: 2023
Reference: JCPP Adv. 2023 Apr 5;3(3):e12158. doi: 10.1002/jcv2.12158. eCollection 2023 Sep.
Impact factor:
Publication type: Paper in international publication
Authors: Brikell, Isabell; Chang, Zheng; Cortese, Samuele; Du Rietz, Ebba; Garcia-Argibay, Miguel; Larsson, Henrik; Li, Lin; Ramos-Quiroga, J Antoni; Ramos-Quiroga, J Antoni; Ribases, Marta et al.
DOI: 10.1002/jcv2.12158